A search for Optimal Cytotoxic Drug as a Partner for the Oral Fluoropyrimidines in the Postoperative Adjuvant Chemotherapy for Gastric Cancer

Yasuhiro Kodera

Abstract

This short communication reflects the authors’ report on feasibility of postoperative adjuvant chemotherapy with S-1 and cisplatin for gastric cancer [1]. In addition, this article summarizes the brief history and current status of the development of postoperative adjuvant chemotherapy in Asia and, in particular, in Japan.